Type 1 diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
Preliminary Wearability study: up to 5 young people aged 5-<18 years living with diabetes attending the Bristol Royal Hospital for Children Diabetes Service will be asked to wear the 'Glucopatch' devi
Sponsors
University of Bristol
Eligibility
Sex/Gender
All
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Child or Young Person living with type 1 diabetes on CGMS and any form of insulin therapy.
Exclusion criteria
Exclusion criteria: Children in diabetes service with any other form of diabetes (Type 2, CFRD, MODY) or not on CGMS for management of diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose measured: 1. From finger-prick blood glucose x 4 a day for 10-14 days (Units being mmol/l ), patient recorded in diary and in dedicated mobile phone app 2. Contemporaneous interstitial glucose measures by Glucopatch (Units mmol/l), recorded by a dedicated mobile phone app 3. Contemporaneous glucose data recorded from currently used CGM (Units mmol/l), downloaded from cloud-based patient records with consent | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualitative data by individual interviews, either face to face or by telephone after the 2-week study period wearing the Glucopatch, will explore the following themes: 1. Previous experience and benefits/issues using current and past CGM 2. Family and patient opinion of Glucopatch 3. Potential benefits of non-invasive technology 4. Potential issues with non-invasive technology 5. Ease of application and removal 6. Any discomfort from using patches | — |
Countries
England, United Kingdom
Contacts
Public ContactJulian Hamilton-Shield
Outcome results
None listed